Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain
- 1 December 2000
- journal article
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 20 (3-4) , 259-269
- https://doi.org/10.1016/s0891-0618(00)00105-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Changes in Serotonin2A and GABAA Receptors in SchizophreniaJournal of Neurochemistry, 1999
- GABA and brain abnormalities in schizophreniaPsychiatry Research: Neuroimaging, 1998
- Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenicsSchizophrenia Research, 1997
- Subgenual prefrontal cortex abnormalities in mood disordersNature, 1997
- Is there evidence for neuronal loss in schizophrenia?International Review of Psychiatry, 1997
- The effects of chronic haloperidol administration on GABA‐immunoreactive. Axon terminals in rat medial prefrontal cortexSynapse, 1994
- Local circuit neurons immunoreactive for calretinin, calbindin D‐28k or parvalbumin in monkey prefronatal cortex: Distribution and morphologyJournal of Comparative Neurology, 1994
- Two Forms of the γ‐Aminobutyric Acid Synthetic Enzyme Glutamate Decarboxylase Have Distinct Intraneuronal Distributions and Cofactor InteractionsJournal of Neurochemistry, 1991
- γ-AMINOBUTYRIC-ACID DEFICIENCY IN BRAIN OF SCHIZOPHRENIC PATIENTSThe Lancet, 1979
- Stereotaxic Anterior Cingulotomy for Neuropsychiatric Illness and Intractable PainJournal of Neurosurgery, 1967